Volcano Corp. has announced it has received FDA clearance for its new intravascular ultrasound catheter, according to a news release. The Visions PV .035 digital IVUS catheter is designed to image ...

Recently, results from Volcano Corporation's (VOLC) PROSPECT (Providing Regional Observations to Study Predictors of Events in the Coronary Tree) study were published in The New England Journal of ...

SAN DIEGO, Sept. 21 /PRNewswire/ -- Volcano Corporation (Nasdaq: VOLC) today announced the company's plans to launch Eagle Eye® Platinum, PrimeWire PRESTIGE™, and the s5™/s5i™ 3.2.1 Software at the ...

Please provide your email address to receive an email when new articles are posted on . IVUS may improve care of patients undergoing peripheral revascularization. More data are needed to document ...

CHICAGO (Reuters) - As U.S. stent makers struggle to address safety concerns over their devices to treat clogged heart arteries, tiny Volcano Corp. believes it has the means to help doctors and ...

Intravascular imaging—whether that’s with IVUS or OCT—improves outcomes across various types of complex coronary lesions when used to guide PCI with drug-eluting stents, a network meta-analysis ...

Amsterdam, the Netherlands - Two US companies are sharing the spoils of Amsterdam cardiovascular device company JOMED, declared bankrupt by the Amsterdam district court in early May 2003. Abbott ...

When used systematically, quantitative coronary angiography (QCA) may be a reasonable alternative to intravascular ultrasound for guidance during percutaneous coronary interventions, new data from the ...

Feb 9 (Reuters) - Volcano Corp said it received marketing clearance from the U.S. health regulator for a new version of its Eagle Eye IVUS catheter, sending its shares up 14 percent before the bell.